Ple123-lacZ (Positive)
|
|
Other constructs for this MiniPromoter: NONE |
|
Other constructs for this Gene: Ple122-lacZ (Positive), Ple124-lacZ (Negative) |
|
|
 |  |  |  |  |  |  | 8.9 weeks, N2, Male (entire series) | 8.9 weeks, N2, Male (entire series) | 8.9 weeks, N2, Male (entire series) | 8.9 weeks, N2, Male (entire series) | 8.9 weeks, N2, Male (entire series) | 8.9 weeks, N2, Male (entire series) | 8.9 weeks, N2, Male (entire series) |
|
|
|
|
|
Ple123-lacZ Description:
The Ple123 promoter construct is derived from the promoter region of the Isoprenylcysteine carboxyl methyltransferase (ICMT) gene. The Pleiades Promoter Project created a 2342 bp MiniPromoter derived from three downstream putative regulatory subregion along with a section of the promoter and introduced it into the multiple cloning site (MCS) of Pleiades expression vector pEMS1313 (LacZ reporter flanked by full frt sites (WT and F5 mutant)) to make plasmid pEMS1594 with Ple123 driving lacZ. The Ple123-lacZ (pEMS1594) was introduced by homologous recombination as single copy insertion into the Hprt1b-m3 locus in the X Chromosome of mouse embryonic stem cells (ESCs) mEMS1202. The resulting PCR validated four ESC lines, mEMS4556, mEMS4548, mEMS4549, and mEMS4567. Chimeras were generated using mEMS4556.
Note: Promoterless negative controls (pEMS1302, pEMS1306, pEMS1313)
have been generated, as well as CAG positive controls (pEMS1157,
pEMS1277 & pEMS1488).
|
|
|
Ple123-lacZ Expression Pattern:
|
|
|
Ple123 MiniPromoter Resources:
|
|
|
Publications:| Reference | PubMed ID |
|---|
| Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Comment in: Nat Neurosci. 2000 Feb;3(2):103-4. Nat Neurosci. 2000 Feb;3(2):157-63. | 10649571 | |
|
|
|
|
|